University of Waterloo and McMaster University, Canada
We will continue to strengthen our strategic collaborations with Canada’s most innovative universities, located in the Toronto area which is the center point for Canada's research and technology hub. More specifically our focus is on various hybrid modeling approaches and mechanistic modeling for monitoring, control and optimization of bioprocesses in biopharma.
The McMaster Advanced Control Consortium (MACC) is one of Canada’s premier process systems engineering research groups. Research in the consortium is conducted by five professors in collaboration with industry partners and focuses on advanced data analytics, process control, and process optimization.
The MACC has a strong background in both multivariate statistics and process control in petrochemicals. Sartorius has been a member of the MACC since 2019 and works closely with consortium members to develop novel modeling and control results in biopharmaceutical applications. Current work is focused on building data-driven models for use in model predictive control of upstream processes.
University of Waterloo
Sartorius has a close partnership with the University of Waterloo, which is consistently ranked as Canada’s most innovative university. Waterloo is home to transformational research and inspired learning and located in the heart of Canada's technology hub, It is constantly growing a network of global partnerships that will shape the future by working beyond disciplines and building bridges with industry, institutions and communities. Waterloo champions a culture of curiosity, exploration, risk-taking, entrepreneurship, global stewardship and leadership and as such is an ideal partner for Sartorius.
We are currently involved with Waterloo University on several levels, including engagement in courses, student projects and Ph.D. research projects, all targeted towards the development of software tools for monitoring, control and optimization of bioprocesses making them more efficient and hence capable of providing high-quality pharmaceuticals for a lower price.